rs587780715

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4BS1BS2

The NM_000455.5(STK11):​c.1254C>G​(p.Cys418Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000422 in 1,564,734 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/15 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C418S) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000046 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000042 ( 0 hom. )

Consequence

STK11
NM_000455.5 missense

Scores

1
12

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:13B:2

Conservation

PhyloP100: 0.505

Publications

4 publications found
Variant links:
Genes affected
STK11 (HGNC:11389): (serine/threonine kinase 11) The protein encoded by this gene is a serine/threonine kinase that regulates cell polarity and energy metabolism and functions as a tumor suppressor. Mutations in this gene have been associated with the autosomal dominant Peutz-Jeghers syndrome, as well as with skin, pancreatic, and testicular cancers. [provided by RefSeq, May 2022]
STK11 Gene-Disease associations (from GenCC):
  • familial pancreatic carcinoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • Peutz-Jeghers syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Orphanet
  • familial ovarian cancer
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.2740425).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000046 (7/152228) while in subpopulation NFE AF = 0.0000882 (6/68018). AF 95% confidence interval is 0.0000376. There are 0 homozygotes in GnomAd4. There are 0 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 7 AD,Unknown gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000455.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
STK11
NM_000455.5
MANE Select
c.1254C>Gp.Cys418Trp
missense
Exon 9 of 10NP_000446.1A0A0S2Z4D1
STK11
NR_176325.1
n.2521C>G
non_coding_transcript_exon
Exon 10 of 11

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
STK11
ENST00000326873.12
TSL:1 MANE Select
c.1254C>Gp.Cys418Trp
missense
Exon 9 of 10ENSP00000324856.6Q15831-1
STK11
ENST00000585748.3
TSL:3
c.882C>Gp.Cys294Trp
missense
Exon 11 of 12ENSP00000477641.2A0A087WT72
STK11
ENST00000593219.6
TSL:3
n.*1079C>G
non_coding_transcript_exon
Exon 10 of 11ENSP00000466610.1K7EMR0

Frequencies

GnomAD3 genomes
AF:
0.0000460
AC:
7
AN:
152228
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000882
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000244
AC:
4
AN:
164078
AF XY:
0.0000222
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000604
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000418
AC:
59
AN:
1412506
Hom.:
0
Cov.:
31
AF XY:
0.0000329
AC XY:
23
AN XY:
698510
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31898
American (AMR)
AF:
0.00
AC:
0
AN:
37556
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25270
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36602
South Asian (SAS)
AF:
0.00
AC:
0
AN:
80444
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48382
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5224
European-Non Finnish (NFE)
AF:
0.0000524
AC:
57
AN:
1088656
Other (OTH)
AF:
0.0000342
AC:
2
AN:
58474
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
5
11
16
22
27
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000460
AC:
7
AN:
152228
Hom.:
0
Cov.:
33
AF XY:
0.00
AC XY:
0
AN XY:
74366
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41460
American (AMR)
AF:
0.00
AC:
0
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5198
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4836
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10630
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000882
AC:
6
AN:
68018
Other (OTH)
AF:
0.00
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.518
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000416

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
6
1
Peutz-Jeghers syndrome (7)
-
2
1
Hereditary cancer-predisposing syndrome (3)
-
3
-
not provided (3)
-
1
-
not specified (1)
-
1
-
Peutz-Jeghers syndrome;C1336708:Germ cell tumor of testis;C1835047:Melanoma, cutaneous malignant, susceptibility to, 1;C2931038:Familial pancreatic carcinoma (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Benign
-0.013
T
BayesDel_noAF
Benign
-0.28
CADD
Benign
18
DANN
Uncertain
0.99
DEOGEN2
Benign
0.26
T
Eigen
Benign
-0.22
Eigen_PC
Benign
-0.31
FATHMM_MKL
Benign
0.59
D
LIST_S2
Benign
0.33
T
M_CAP
Benign
0.029
D
MetaRNN
Benign
0.27
T
MetaSVM
Benign
-0.95
T
PhyloP100
0.51
Sift4G
Benign
0.39
T
Vest4
0.34
MVP
0.81
ClinPred
0.32
T
GERP RS
0.87
Varity_R
0.17
Mutation Taster
=82/18
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs587780715; hg19: chr19-1226598; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.